Unichem Laboratories

Unichem Laboratories FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Unichem Laboratories (UNICHEMLAB.NS) as of Oct 29, 2026 is -105.48 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -4.65 % — a change of 2,168.36% (lower).

FCF Conversion

-105.48 %

YoY

2,168.36%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Unichem Laboratories is 2025 -105.48 % . FCF Conversion Rate (FCF/EBITDA) of Unichem Laboratories was 2024 -4.65 % . It decreases by 2,168.36% lower compared to the previous year.

The Unichem Laboratories FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-10.68 INR
Jan 1, 2019
2,193.56 INR
Jan 1, 2020
608.71 INR
Jan 1, 2021
-719.96 INR
Jan 1, 2022
-1,169.37 INR
Jan 1, 2023
45.13 INR
Jan 1, 2024
-4.65 INR
Jan 1, 2025
-105.48 INR
The Unichem Laboratories FCF Conversion history
YEARFCF ConversionYoY
-105.48 %+2,168.36%
-4.65 %-110.30%
45.13 %-103.86%
-1,169.37 %+62.42%
-719.96 %-218.28%
608.71 %-72.25%
2,193.56 %-20,630.43%
-10.68 %-85.78%
-75.13 %+62.91%
-46.12 %+5,858.60%
-0.77 %-92.42%
-10.21 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Unichem Laboratories Stock analysis

What does Unichem Laboratories do? Unichem Laboratories Ltd. generates revenue through the manufacturing and marketing of pharmaceutical formulations, including branded generics and generics across global markets. The company develops and produces complex active pharmaceutical ingredients (API) and dosage forms, targeting therapeutic areas such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives, and pain management. Its subsidiaries, Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta, and Niche Generics Limited UK, support its international operations. Contract manufacturing services for immediate-release and extended-release dosage forms, dry powder injections, syrups, and novel drug delivery systems also contribute to its revenue streams. The company sells its products to healthcare providers, hospitals, and pharmacies worldwide, leveraging its focus on product development and process chemistry. Unichem Pharmaceuticals (USA) Inc and Unichem Farmaceutica Do Brasil Lta serve as key regional entities for market expansion, while Niche Generics Limited UK facilitates operations in the European market. The firm's portfolio includes both branded generics and generic formulations, catering to diverse therapeutic needs across multiple geographies. Unichem Laboratories Ltd. emphasizes technology transfer and documentation in its contract manufacturing services, which are sought by partners in the pharmaceutical industry. The company's product range addresses critical healthcare segments, ensuring consistent demand for its formulations. Its global presence, supported by subsidiaries in the USA, Brazil, and the UK, enables it to serve international clients effectively. Unichem Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Unichem Laboratories stock

FCF Conversion Rate (FCF/EBITDA) of Unichem Laboratories is -105.48 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Unichem Laboratories changed from -4.65 % to -105.48 %, representing a 2,168.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Unichem Laboratories since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Unichem Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Unichem Laboratories

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Unichem Laboratories